Alnylam Pharmaceuticals, Inc.
Nasdaq: ALNY
- 90 clinical trials, 26 active
- 1 FDA-registered drug site
- Research grants: $590,073
Life science companies
Explore 12,266 biotech, pharmaceutical, medical device, CRO and CDMO companies. Filter by type, location, clinical trials, funding, FDA registrations and research focus, then see the insights or the map. Free, and new companies are added every day.
Catheter Precision, Inc.
NYSE: VTAK
- Raised $8 million (2023)
- 2 clinical trials
- FDA-cleared or approved devices
Prenosis, Inc.
- Raised $1.5 million (2016)
- 2 clinical trials, 2 active
- FDA-cleared or approved devices
- Research grants: $18 million
Sorrento Therapeutics, Inc.
- Raised $1.9 million (2013)
- 46 clinical trials, 2 active
- Research grants: $4.8 million
- Founded 2006
Spectral MD, Inc.
- Raised $1.1 million (2018)
- 7 clinical trials, 1 active
- FDA-cleared or approved devices
- Research grants: $503,074
EBR Systems, Inc.
OTC: NONE.
- Raised $8.7 million (2021)
- 6 clinical trials, 4 active
- FDA-cleared or approved devices
Kineta, Inc.
- Raised $17 million (2022)
- 4 clinical trials
- Research grants: $11 million
- Founded 2007
Solta Medical Inc
- Raised $25 million (2013)
- 4 clinical trials
- FDA-cleared or approved devices
Fractyl Health, Inc.
Nasdaq: GUTS
- Raised $100 million (2021)
- 7 clinical trials, 1 active
- 1 FDA-registered device site
- Founded 2010
INVO Fertility, Inc.
Nasdaq: IVF
- Raised $3 million (2023)
- 3 clinical trials
- FDA-cleared or approved devices
Sequitur Health Corp.
- Raised $3,000 (2017)
- 1 clinical trial, 1 active
- FDA-cleared or approved devices
- Research grants: $14 million
Tactile Systems Technology Inc
Nasdaq: TCMD
- Raised $10 million (2012)
- 1 clinical trial
- FDA-cleared or approved devices
- Founded 2006
Veracyte, Inc.
Nasdaq: VCYT
- Raised $13 million (2014)
- 2 clinical trials, 2 active
- 1 FDA-registered device site
- Founded 2006
Anika Therapeutics, Inc.
Nasdaq: ANIK
- 17 clinical trials, 2 active
- FDA-cleared or approved devices
- 1 FDA-registered drug site
Visterra, Inc.
- Raised $34 million (2013)
- 4 clinical trials
- Research grants: $299,980
- Founded 2007
Envoy Medical, Inc.
Nasdaq: COCH
- Raised $330,000 (2010)
- 4 clinical trials, 1 active
- FDA-cleared or approved devices
- Research grants: $100,000
Inogen Inc
Nasdaq: INGN
- Raised $9.6 million (2010)
- 6 clinical trials, 1 active
- FDA-cleared or approved devices
Merit Medical Systems Inc
Nasdaq: MMSI
- 30 clinical trials, 8 active
- FDA-cleared or approved devices
RenovoRx, Inc.
Nasdaq: RNXT
- Raised $10 million (2026)
- 4 clinical trials, 2 active
- FDA-cleared or approved devices
- Founded 2012
Abeona Therapeutics Inc.
Nasdaq: ABEO
- Raised $14 million (2015)
- 13 clinical trials, 5 active
- 1 FDA-registered drug site
- Founded 2013
Precigen, Inc.
Nasdaq: PGEN
- Raised $13 million (2020)
- 6 clinical trials, 5 active
- 1 FDA-registered drug site
Alphatec Holdings, Inc.
Nasdaq: ATEC
- Raised $30 million (2020)
- FDA-cleared or approved devices
Resmed Inc
NYSE: RMD
- 107 clinical trials, 14 active
- FDA-cleared or approved devices
Codagenix Inc.
- Raised $25 million (2023)
- 8 clinical trials
- Research grants: $15 million
ONL Therapeutics, Inc.
- Raised $60 million (2024)
- 5 clinical trials, 1 active
- Research grants: $7 million
- Founded 2011
Alleviant Medical, Inc.
- Raised $91 million (2025)
- 6 clinical trials, 2 active
- Research grants: $10 million
- Founded 2017
Route 92 Medical, Inc.
- Raised $50 million (2026)
- 3 clinical trials, 1 active
- FDA-cleared or approved devices
Immunocore Holdings plc
Nasdaq: IMCR
- Raised $140 million (2022)
- Founded 2021
Allurion Technologies, Inc.
OTC: ALUR
- Raised $5 million (2025)
- 5 clinical trials, 2 active
- FDA-cleared or approved devices
- Founded 2010
iSono Health, Inc.
- Raised $1.8 million (2025)
- 1 clinical trial, 1 active
- FDA-cleared or approved devices
- Research grants: $4 million
Tenon Medical, Inc.
Nasdaq: TNON
- Raised $4.3 million (2026)
- 2 clinical trials
- FDA-cleared or approved devices
- Founded 2012
Alkermes Inc
- 98 clinical trials, 8 active
- 2 FDA-registered drug sites
- Research grants: $2.9 million
Lyndra Therapeutics, Inc.
- Raised $123 million (2023)
- 7 clinical trials
- Research grants: $6 million
- Founded 2015
Embecta Corp.
Nasdaq: EMBC
- 1 clinical trial
- FDA-cleared or approved devices
- 1 FDA-registered drug site
Day One Biopharmaceuticals, Inc.
- Raised $130 million (2021)
- 8 clinical trials, 4 active
- 1 FDA-registered drug site
- Founded 2018
Seres Therapeutics, Inc.
Nasdaq: MCRB
- Raised $65 million (2015)
- 8 clinical trials
- 1 FDA-registered drug site
- Founded 2010
Adaptimmune Therapeutics PLC
- Raised $104 million (2014)
- 13 clinical trials
- Founded 2014
Lumos Pharma, Inc.
- Raised $34 million (2016)
- 42 clinical trials, 6 active
- Research grants: $1.1 million
- Founded 2014
Delphinus Medical Technologies, Inc.
- Raised $28 million (2025)
- 5 clinical trials
- Research grants: $9.1 million
- Founded 2010
Omeros Corp
Nasdaq: OMER
- Private funding (2010)
- 25 clinical trials, 3 active
- Research grants: $5.4 million
Summit Therapeutics Inc.
Nasdaq: SMMT
- Raised $235 million (2024)
- 14 clinical trials, 7 active
- Founded 2020
Rhaeos Inc.
- Raised $6.2 million (2023)
- 16 clinical trials, 10 active
- Research grants: $12 million
- Founded 2018
Chinook Therapeutics, Inc.
- Raised $51 million (2015)
- 11 clinical trials
- Research grants: $684,763
- Founded 2011
Coherus Oncology, Inc.
Nasdaq: CHRS
- Raised $6.8 million (2017)
- 19 clinical trials, 6 active
- 2 FDA-registered drug sites
- Founded 2010
Editas Medicine, Inc.
Nasdaq: EDIT
- Raised $120 million (2015)
- 5 clinical trials, 3 active
- Research grants: $225,000
- Founded 2013
Jupiter Neurosciences, Inc.
Nasdaq: JUNS
- Raised $100,000 (2017)
- 1 clinical trial
- Research grants: $4 million
- Founded 2016
Trellis Bioscience, Inc.
- Raised $6.1 million (2026)
- 5 clinical trials, 2 active
- Research grants: $55 million
- Founded 2010
Nextstep Robotics, Inc.
- Raised $450,000 (2019)
- 2 clinical trials, 1 active
- 1 FDA-registered device site
- Research grants: $11 million
Centerline Biomedical, Inc.
- Raised $11 million (2025)
- FDA-cleared or approved devices
- Research grants: $6.8 million
Globus Medical Inc
NYSE: GMED
- 16 clinical trials, 2 active
- FDA-cleared or approved devices
Published company profiles only; counts update daily. Data licences